MoneyWorks4Me

Lyka Labs - Quaterly Results

26 May 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 305.17 millions, up 13.09% as compared to Rs. 269.84 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2025 of Rs. 13.07 millions grew from Rs.-16.22 millionsOperating Profit saw a handsome growth to 41.30 millions from 26.05 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 305.17 269.84 13.09 1346.97 1063.96 26.60 1346.97 1063.96 26.60
Other Income 7.20 3.90 84.62 23.44 16.47 42.32 23.44 16.47 42.32
PBIDT 41.30 26.05 58.54 202.32 162.07 24.83 202.32 162.07 24.83
Interest 5.20 10.35 -49.76 23.04 47.98 -51.98 23.04 47.98 -51.98
PBDT 36.10 15.60 131.41 179.28 113.54 57.90 179.28 113.54 57.90
Depreciation 13.38 27.72 -51.73 64.53 122.87 -47.48 64.53 122.87 -47.48
PBT 22.72 -12.12 -287.46 114.75 -9.33 -1329.90 114.75 -9.33 -1329.90
TAX 9.65 4.10 135.37 32.47 13.37 142.86 32.47 13.37 142.86
Deferred Tax 3.45 0.55 527.27 5.23 -2.63 -298.86 5.23 -2.63 -298.86
PAT 13.07 -16.22 -180.58 82.28 -22.70 -462.47 82.28 -22.70 -462.47
Equity 356.90 330.90 7.86 356.90 330.90 7.86 356.90 330.90 7.86
PBIDTM(%) 13.53 9.65 40.19 15.02 15.23 -1.39 15.02 15.23 -1.39
Peers
Company Name CMP
Sun Pharma. Inds. 1850.00
Dr. Reddys Labs. 1202.70
Cipla 1399.90
Lupin 2094.45
Zydus Lifesciences 1184.75
View more..